HK1066547A1 - Derivatives of 5-(pyridin-3-yl)-1-azabicyclo (3.2.1) ocatane, the preparation thereof and the application of same in therapeutics - Google Patents

Derivatives of 5-(pyridin-3-yl)-1-azabicyclo (3.2.1) ocatane, the preparation thereof and the application of same in therapeutics

Info

Publication number
HK1066547A1
HK1066547A1 HK04109549A HK04109549A HK1066547A1 HK 1066547 A1 HK1066547 A1 HK 1066547A1 HK 04109549 A HK04109549 A HK 04109549A HK 04109549 A HK04109549 A HK 04109549A HK 1066547 A1 HK1066547 A1 HK 1066547A1
Authority
HK
Hong Kong
Prior art keywords
ocatane
azabicyclo
pyridin
therapeutics
derivatives
Prior art date
Application number
HK04109549A
Other languages
English (en)
Inventor
Frederic Galli
Odile Leclerc
Alistair Lochead
Alain Nedelec
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of HK1066547A1 publication Critical patent/HK1066547A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HK04109549A 2002-01-07 2004-12-02 Derivatives of 5-(pyridin-3-yl)-1-azabicyclo (3.2.1) ocatane, the preparation thereof and the application of same in therapeutics HK1066547A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0200109A FR2834511B1 (fr) 2002-01-07 2002-01-07 Derives de 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, leur preparation et leur application en therapeutique
PCT/FR2003/000004 WO2003057697A1 (fr) 2002-01-07 2003-01-03 Derives de 5-(pyridin-3-yl)-1-azabicyclo [3.2.1] octane, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
HK1066547A1 true HK1066547A1 (en) 2005-03-24

Family

ID=8871176

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04109549A HK1066547A1 (en) 2002-01-07 2004-12-02 Derivatives of 5-(pyridin-3-yl)-1-azabicyclo (3.2.1) ocatane, the preparation thereof and the application of same in therapeutics

Country Status (36)

Country Link
US (2) US7223750B2 (de)
EP (1) EP1465893B1 (de)
JP (1) JP4402957B2 (de)
KR (1) KR100977332B1 (de)
CN (2) CN1911928A (de)
AR (2) AR038098A1 (de)
AT (1) ATE355290T1 (de)
AU (1) AU2003216777B2 (de)
BR (1) BR0306707A (de)
CA (1) CA2471628C (de)
CO (1) CO5590914A2 (de)
CY (1) CY1106580T1 (de)
DE (1) DE60312123T2 (de)
DK (1) DK1465893T3 (de)
EA (1) EA007793B1 (de)
EC (1) ECSP045176A (de)
ES (1) ES2281631T3 (de)
FR (1) FR2834511B1 (de)
HK (1) HK1066547A1 (de)
HR (1) HRP20040617B1 (de)
IL (2) IL162524A0 (de)
IS (1) IS2470B (de)
MA (1) MA27165A1 (de)
ME (2) MEP24408A (de)
MX (1) MXPA04006630A (de)
NO (1) NO329309B1 (de)
NZ (1) NZ533793A (de)
PL (1) PL216665B1 (de)
PT (1) PT1465893E (de)
RS (1) RS50921B (de)
SI (1) SI1465893T1 (de)
TN (1) TNSN04120A1 (de)
TW (1) TWI336703B (de)
UA (1) UA77229C2 (de)
WO (1) WO2003057697A1 (de)
ZA (1) ZA200405002B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9902007D0 (en) * 1999-01-30 1999-03-17 Thomas Carpentry Services Limi Improvements relating to door frames
FR2834511B1 (fr) * 2002-01-07 2004-02-13 Sanofi Synthelabo Derives de 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, leur preparation et leur application en therapeutique
FR2889701B1 (fr) * 2005-08-12 2007-10-05 Sanofi Aventis Sa Derives de 5-pyridinyl-1-azabicyclo[3.2.1]octane, leur preparation en therapeutique.
FR2889847B1 (fr) 2005-08-18 2007-10-05 Sanofi Aventis Sa Derives de 5-pyridazinyl-1-azabicyclo[3.2.1]octave, leur preparation en therapeutique.
FR2912404B1 (fr) * 2007-02-09 2009-04-10 Sanofi Aventis Sa Derives d'azabicycloalkane,leur preparation et leur application en therapeutique.
KR101928505B1 (ko) * 2011-01-28 2018-12-12 에스케이바이오팜 주식회사 피리돈 유도체 및 이를 포함하는 약학적 조성물
KR101925971B1 (ko) 2011-01-28 2018-12-06 에스케이바이오팜 주식회사 피리돈 유도체 및 이를 포함하는 약학적 조성물
CA3205816A1 (en) 2017-11-03 2019-05-09 Alcon Inc. Azabicyclo and diazepine derivatives for treating ocular disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5817679A (en) * 1993-04-01 1998-10-06 University Of Virginia 7-Azabicyclo 2.2.1!-heptane and -heptene derivatives as cholinergic receptor ligands
WO1995003306A1 (en) 1993-07-22 1995-02-02 E.I. Du Pont De Nemours And Company Arthropodicidal azacyclic heterocycles
FR2786770B1 (fr) * 1998-12-04 2001-01-19 Synthelabo Derives de 1,4-diazabicyclo[3.2.2.]nonane, leur preparation et leur application en therapeutique
FR2786769B1 (fr) * 1998-12-04 2002-10-25 Synthelabo Derives de 2,5-diazabicyclo[2.2.1]heptane, leur preparation et leur application en therapeutique
FR2834511B1 (fr) * 2002-01-07 2004-02-13 Sanofi Synthelabo Derives de 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
NZ533793A (en) 2007-01-26
CN1911928A (zh) 2007-02-14
CN1276921C (zh) 2006-09-27
FR2834511A1 (fr) 2003-07-11
CA2471628C (en) 2011-03-22
MEP24408A (en) 2010-10-10
HRP20040617A2 (en) 2004-10-31
ME00213B (me) 2011-02-10
ZA200405002B (en) 2006-05-31
TW200305413A (en) 2003-11-01
DE60312123T2 (de) 2007-09-13
AR038098A1 (es) 2004-12-29
RS59904A (en) 2006-10-27
PL216665B1 (pl) 2014-04-30
US20050020568A1 (en) 2005-01-27
KR100977332B1 (ko) 2010-08-20
MXPA04006630A (es) 2004-11-10
SI1465893T1 (sl) 2007-08-31
PT1465893E (pt) 2007-05-31
AU2003216777B2 (en) 2008-10-02
JP2005514422A (ja) 2005-05-19
CA2471628A1 (en) 2003-07-17
RS50921B (sr) 2010-08-31
DE60312123D1 (de) 2007-04-12
TWI336703B (en) 2011-02-01
PL370065A1 (en) 2005-05-16
CO5590914A2 (es) 2005-12-30
EP1465893A1 (de) 2004-10-13
IS2470B (is) 2008-12-15
AR086573A2 (es) 2014-01-08
MA27165A1 (fr) 2005-01-03
WO2003057697A1 (fr) 2003-07-17
NO20042846L (no) 2004-09-21
AU2003216777A1 (en) 2003-07-24
UA77229C2 (uk) 2006-11-15
IL162524A (en) 2010-05-17
HRP20040617B1 (hr) 2012-10-31
BR0306707A (pt) 2005-02-09
US20070185137A1 (en) 2007-08-09
ECSP045176A (es) 2004-08-27
DK1465893T3 (da) 2007-06-04
NO329309B1 (no) 2010-09-27
ATE355290T1 (de) 2006-03-15
IL162524A0 (en) 2005-11-20
TNSN04120A1 (fr) 2006-06-01
US7585974B2 (en) 2009-09-08
IS7322A (is) 2004-06-16
ES2281631T3 (es) 2007-10-01
KR20040077705A (ko) 2004-09-06
CN1612876A (zh) 2005-05-04
EA007793B1 (ru) 2007-02-27
CY1106580T1 (el) 2012-01-25
JP4402957B2 (ja) 2010-01-20
US7223750B2 (en) 2007-05-29
EP1465893B1 (de) 2007-02-28
EA200400770A1 (ru) 2004-12-30
FR2834511B1 (fr) 2004-02-13

Similar Documents

Publication Publication Date Title
IL211281A (en) History of triazolo [4,2,1] pyridine [a – 4,3] and their pharmaceutical preparations
AU3301800A (en) 1,4-diazabicyclo(3.2.2)nonane-4-carboxylate and carboxamide derivatives, production and use thereof in therapeutics
PL392790A1 (pl) Związki pirazolo [3, 4-b] pirydynowe i ich zastosowanie jako inhibitorów fosfodiesterazy
AU2003262262A1 (en) Pyrazole derivatives, medicinal composition containing the same, and medicinal use thereof
HK1068895A1 (en) Nitrogen-containing heterocyclic derivative, medicinal composition containing the same, medicinal use thereof, and intermediate therefor
HK1082744A1 (en) Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof
IL166129A (en) Annals of 5 - (h1 - indoliloxy) - pyrollo [1,2 - f] [4,2,1] Triazine and Pharmaceuticals containing them
PT1478339E (pt) Formulações farmacêuticas de agentes antineoplásticos, em particular temozolomida, processos para a sua produção e utilização
HK1167332A1 (en) Pharmaceutical composition, use thereof and method for making the same
AU2003289440A1 (en) Nitrogen-containing heterocycic derivatives, medicinal compositions containing the same and medicinal use thereof
AU2003289641A1 (en) The novel coumarin-amide derivatives and its preparation, said drug composition and its use
SI1499589T1 (sl) Derivati N-(fenil(piperidin-2-il)metil)benzamida,njihova priprava in njihova terapevtska uporaba
ZA200706953B (en) (1,5-diphenyl-1h-pyrazol-3-yl) oxadiazole derivatives, preparation method thereof and use same in therapeutics
ZA200410211B (en) Quinuclidine derivatives and pharmaceutical compositions containing the same.
HUP0401638A3 (en) Thiopene-amides, thiazolesulfonamides as antineoplastic agents, and pharmaceutical composition containing the same
NO20043565L (no) Heteroaryl-substituerte 2-pyridinyl- og 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-on-derivater.
IL166821A0 (en) Novel 1,4-diazabicycloalkane derivatives their preparation and use
ZA200307306B (en) Indolines, substituted in portion 6, and their use as kinase inhibitors.
HUP0303155A3 (en) 2-thio-substituted imidazole derivatives, the use thereof and pharmaceutical compositions containing them
HK1066547A1 (en) Derivatives of 5-(pyridin-3-yl)-1-azabicyclo (3.2.1) ocatane, the preparation thereof and the application of same in therapeutics
AP2329A (en) 2-Substituted phenyl-5, 7-dihydrocarbyl-3, 7-dihydropyrrolo [2,3-d] pyrimidin-4 - one derivatives, the preparation and the pharmaceutical use thereof.
AU2003272903A1 (en) Pyrazole derivative, medicinal composition containing the same, medicinal use thereof and intermediate in producing the same
TWI320413B (en) 1,4-diazabicyclo [ 3.2.2 ] nonanecarboxamide derivatives, preparation thereof and therapeutic use thereof
SI1922320T1 (sl) Derivati 5-piridazinil-1-azabiciklo(3.2.1)oktana, njihova priprava in njihova terapevtska uporaba
AU2003292285A1 (en) Pyridoindolone derivatives substituted in the 3-position by a heterocyclic group, preparation thereof and application of same in therapeutics

Legal Events

Date Code Title Description
CHPA Change of a particular in the register (except of change of ownership)
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20180103